Taxonomy: Bacteria; Firmicutes; Bacilli; Bacillales; Staphylococcaceae;

Staphylococcus

Staphylococcus search

Read about Staphylococcus:

Hide info

Staphylococcus aureus

I. Organism Information

A. Taxonomy Information

1. Species

a. Staphylococcus aureus

i. Taxonomy ID: 1280

ii. Description:

Staphylococcus aureus is a Gram-positive pathogen that causes a wide range of diseases, and is becoming increasingly resistant to antibiotics (1). These resistant bacteria are called methicillin-resistant Staphylococcus aureus, or MRSA. S. aureus is responsible for a variety of ailments, including carbuncles, food poisoning, wound and medical device-related infections, bacteremia, necrotizing pneumonia, and endocarditis (2). S. aureus forms a fairly large yellow colony on rich medium and is hemolytic on blood agar. Staphylococci are facultative anaerobes that ferment glucose to lactate. The bacteria are catalase-positive and oxidase-negative. S. aureus can grow at a temperature range of 15 to 45 degrees and at NaCl concentrations as high as 15 percent. Almost all strains of S. aureus produce the enzyme coagulase. S. aureus should always be considered a potential pathogen (3).

To contribute more information, please contact help@nmpdr.org

iii. Variants

Staphylococcus aureus subsp. aureus
Taxonomy ID: 46170

Staphylococcus aureus subsp. aureus COL
Taxonomy ID: 93062
Parent: Staphylococcus aureus subsp. aureus

Staphylococcus aureus subsp. aureus MRSA252
Taxonomy ID: 282458
Parent: Staphylococcus aureus subsp. aureus

Staphylococcus aureus subsp. aureus MSSA476
Taxonomy ID: 282459
Parent: Staphylococcus aureus subsp. aureus

Staphylococcus aureus subsp. aureus MW2
Taxonomy ID: 196620

Parent: Staphylococcus aureus subsp. aureus

Staphylococcus aureus subsp. aureus Mu50
Taxonomy ID: 158878
Parent: Staphylococcus aureus subsp. aureus

Staphylococcus aureus subsp. aureus N315
Taxonomy ID: 158879
Parent: Staphylococcus aureus subsp. aureus

B. Lifecycle and Morphology

1. (To contribute to this description of the infection cycle, please contact help@nmpdr.org)

a. Shape:

Cocci 0.5-1.0 μm in diameter. Cells occur singly or in pairs. Division is in two planes, giving rise to clusters. Colonies are smooth, raised, glistening, circular, entire and translucent. Single colonies may obtain a size of 6-8 mm in diameter (4).

b. Picture:

SEM of Staphylococcus aureus
SEM of numerous clumps of methicillin-resistant Staphylococcus aureus bacteria, commonly referred to by the acronym, MRSA (magnified 9560x), by Janice Carr, CDC

C. Genome Summary

1. Genome of Staphylococcus aureus subsp. aureus COL

a. Chromosome

i. Genbank Accession Number: NC_002951
ii. Size: 2,809,422 bp
iii. S. aureus COL is an early methicillin-resistant isolate (5).

b. Plasmid pT181

i. Genbank Accession Number: NC_006629
ii. Size: 4,440 bp



II. References

1.  Sanger Institute

2.  Holden MT, Feil EJ, Lindsay JA, Peacock SJ, Day NP, Enright MC, Foster TJ, Moore CE, Hurst L, Atkin R, Barron A, Bason N, Bentley SD, Chillingworth C, Chillingworth T, Churcher C, Clark L, Corton C, Cronin A, Doggett J, Dowd L, Feltwell T, Hance Z, Harris B, Hauser H, Holroyd S, Jagels K, James KD, Lennard N, Line A, Mayes R, Moule S, Mungall K, Ormond D, Quail MA, Rabbinowitsch E, Rutherford K, Sanders M, Sharp S, Simmonds M, Stevens K, Whitehead S, Barrell BG, Spratt BG, Parkhill J. (2004) Complete genomes of two clinical Staphylococcus aureus strains: evidence for the rapid evolution of virulence and drug resistance. Proc. Natl. Acad. Sci. USA. 101: 9786-91.

3.   http://textbookofbacteriology.net/staph.html


4.   Bergey's Manual of Determinative Bacteriology, 9th edition. John G. Holt, Noel R. Krieg, Peter H.A. Sneath, James T. Staley, and Stanley T. Williams, editors. Baltimore: Williams and Wilkins, 1994, pp. 518.

5.   Gill SR, Fouts DE, Archer GL, Mongodin EF, Deboy RT, Ravel J, Paulsen IT, Kolonay JF, Brinkac L, Beanan M, Dodson RJ, Daugherty SC, Madupu R, Angiuoli SV, Durkin AS, Haft DH, Vamathevan J, Khouri H, Utterback T, Lee C, Dimitrov G, Jiang L, Qin H, Weidman J, Tran K, Kang K, Hance IR, Nelson KE, and Fraser CM. (2005) Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J. Bacteriol. 187: 2426-2438.

Hide info

Hide info

Staphylococcus - Google News

©2016 Google

Suffering with eczema? Condition could be triggered by FATAL Staphylococcus bacteria - Express.co.uk


Express.co.uk

Suffering with eczema? Condition could be triggered by FATAL Staphylococcus bacteria
Express.co.uk
... the golden appearance on a culture plate (aureus: 'golden')." He added: "In recent decades, S. aureus has become increasingly resistant against our most common antibiotics, leading to the superbug Methicillin Resistant Staphylococcus aureus: MRSA.".
Methicillin-Resistant Staphylococcus aureus (MRSA) Infections Pipeline Review H2 2015Medgadget.com (blog)

all 2 news articles »

Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Clinical Trials Review 2016 By Global Market ... - Medgadget.com (blog)


Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Clinical Trials Review 2016 By Global Market ...
Medgadget.com (blog)
Methicillin-Resistant-Staphylococcus-Aureus-MRSA-Infections Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections Global 2016 Clinical Trials Review, H2 provides an detailed overview of Methicillin-Resistant Staphylococcus Aureus (MRSA) ...
Global Staphylococcus Aureus Infections Pipeline Review, H2 2015 - 100+ Companies and their Drug Profiles ...Business Wire (press release)

all 2 news articles »

Staphylococcus aureus Infections Pipeline Review, Industry Analysis, Market Size and Forecast 2016 2020 - Medgadget.com (blog)


Staphylococcus aureus Infections Pipeline Review, Industry Analysis, Market Size and Forecast 2016 2020
Medgadget.com (blog)
MRS161 Staphylococcus aureus Infections Global 2015 Clinical Trials Review, H2 provides an detailed overview of Staphylococcus aureus Infections scenario. Report includes top line data relating on Staphylococcus aureus Infections Global clinical ...

Lupus risk associated with chronic exposure to staph (staphylococcus aureus) bacteria - Bel Marra Health


Bel Marra Health

Lupus risk associated with chronic exposure to staph (staphylococcus aureus) bacteria
Bel Marra Health
Lupus risk associated with chronic exposure to staph (staphylococcus aureus) bacteria Lupus risk is associated with chronic exposure to staph (staphylococcus aureus) bacteria. A study from the Mayo Clinic revealed that chronic exposure to staph even ...

Global Drugs For Vancomycin Resistant Staphylococcus Aureus Infection (VRSA) Industry 2015 Market Research ... - Medgadget.com (blog)


Global Drugs For Vancomycin Resistant Staphylococcus Aureus Infection (VRSA) Industry 2015 Market Research ...
Medgadget.com (blog)
The Drugs For Vancomycin Resistant Staphylococcus Aureus Infection (VRSA) industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

Global Staphylococcus aureus Infections Clinical Trials Review, H2, 2015 - Research and Markets - Business Wire (press release)


Sacramento Magazine

Global Staphylococcus aureus Infections Clinical Trials Review, H2, 2015 - Research and Markets
Business Wire (press release)
This report provides top line data relating to the clinical trials on Staphylococcus aureus Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of ...
Staphylococcus aureus Infections Global Clinical Trials Review, H2, 2015 Research ReportMedgadget.com (blog)

all 72 news articles »

Vancomycin-Resistant Staphylococcus Aureus (VRSA) Infections Therapeutics Pipeline Review, H2 2015 - Research ... - Business Wire (press release)


Vancomycin-Resistant Staphylococcus Aureus (VRSA) Infections Therapeutics Pipeline Review, H2 2015 - Research ...
Business Wire (press release)
This report provides comprehensive information on the therapeutic development for Vancomycin-Resistant Staphylococcus Aureus (VRSA) Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism ...

and more »

Global Methicillin-Resistant Staphylococcus Aureus Clinical Trials Review 2016 By Market Research Store - Medgadget.com (blog)


Global Methicillin-Resistant Staphylococcus Aureus Clinical Trials Review 2016 By Market Research Store
Medgadget.com (blog)
Report includes top line data relating on Methicillin-Resistant Staphylococcus Aureus Global clinical trials scenario. This report on Methicillin-Resistant Staphylococcus Aureus also includes an review of trial numbers as well as their (Methicillin ...

UC San Diego researchers develop rapid susceptibility test for Staphylococcus aureus - News-Medical.net


Genetic Engineering & Biotechnology News (blog)

UC San Diego researchers develop rapid susceptibility test for Staphylococcus aureus
News-Medical.net
In a paper published online this week in the journal EBioMedicine, the scientists reported the development of a rapid susceptibility test for Staphylococcus aureus, a bacterium that causes some 60 percent of hospital-acquired infections and which has ...
Fast Test for Antibiotic Susceptibility DevelopedGenetic Engineering & Biotechnology News (blog)

all 3 news articles »

World Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections Therapeutic Development Pipeline Review ... - Business Wire (press release)


World Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections Therapeutic Development Pipeline Review ...
Business Wire (press release)
This report provides comprehensive information on the therapeutic development for Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism ...

and more »

Hide info

Staphylococcus genome sequence annotation status: click numbers to browse lists of genes or subsystems

Strain annotated in NMPDR Phenotype Genome size, bp Protein Encoding Genes (PEGs) Sort Named genes in subsystems Named genes not in subsystems Hypothetical genes in subsystems Hypothetical genes not in subsystems Subsystems RNAs
Staphylococcus aureus RF122 Bovine mastitis 2,742,531 2,523 1213(45.4%) 731(27.4%) 113(4.2%) 615(23.0%) 316 110
Staphylococcus aureus subsp. aureus COL methicillin resistant, hospital acquired (MRSA) 2,813,862 2,622 1247(44.8%) 718(25.8%) 98(3.5%) 722(25.9%) 330 108
Staphylococcus aureus subsp. aureus JH1 vancomycin susceptible, hospital acquired (MRSA) 2,879,577 2,685 1194(43.4%) 779(28.3%) 110(4.0%) 666(24.2%) 314 172
Staphylococcus aureus subsp. aureus JH9 vancomycin nonsusceptible, isogenic to JH1, hospital acquired (MRSA, VISA) 2,862,918 2,675 1202(43.9%) 773(28.2%) 108(3.9%) 657(24.0%) 316 165
Staphylococcus aureus subsp. aureus MRSA252 methicillin resistant, hospital acquired (MRSA) 2,902,619 2,663 1254(45.7%) 756(27.5%) 77(2.8%) 659(24.0%) 338 110
Staphylococcus aureus subsp. aureus MSSA476 methicillin susceptible, community acquired 2,820,454 2,609 1231(45.1%) 763(28.0%) 82(3.0%) 652(23.9%) 335 157
Staphylococcus aureus subsp. aureus MW2 methicillin resistant, community acquired (CA-MRSA) 2,820,462 2,644 1202(43.7%) 790(28.7%) 92(3.3%) 669(24.3%) 337 53
Staphylococcus aureus subsp. aureus Mu3   2,880,168 2,495 1094(43.7%) 768(30.7%) 90(3.6%) 549(22.0%) 296 108
Staphylococcus aureus subsp. aureus Mu50 methicillin and vancomycin resistant, hospital acquired (MRSA, VRSA) 2,903,147 2,771 1293(44.0%) 818(27.9%) 142(4.8%) 683(23.3%) 337 108
Staphylococcus aureus subsp. aureus N315 methicillin resistant, hospital acquired (MRSA) 2,839,469 2,648 1279(45.3%) 814(28.9%) 90(3.2%) 638(22.6%) 340 110
Staphylococcus aureus subsp. aureus NCTC 8325 lab strain 2,821,361 2,895 1222(39.9%) 832(27.1%) 110(3.6%) 901(29.4%) 320 109
Staphylococcus aureus subsp. aureus USA300 methicillin resistant, community acquired (CA-MRSA) 2,917,469 2,607 1223(44.1%) 833(30.1%) 86(3.1%) 629(22.7%) 316 105
Staphylococcus aureus subsp. aureus str. Newman   2,878,897 2,523 1077(42.6%) 782(30.9%) 71(2.8%) 599(23.7%) 293 109
Staphylococcus epidermidis ATCC 12228   2,564,615 2,472 1147(44.7%) 723(28.2%) 47(1.8%) 647(25.2%) 325 118
Staphylococcus epidermidis RP62A   2,643,840 2,529 1122(42.7%) 678(25.8%) 45(1.7%) 780(29.7%) 316 120
Staphylococcus haemolyticus JCSC1435   2,697,861 2,694 1164(41.8%) 773(27.7%) 53(1.9%) 796(28.6%) 323 111
Staphylococcus saprophyticus subsp. saprophyticus ATCC 15305   2,577,899 2,517 1140(43.7%) 765(29.3%) 42(1.6%) 662(25.4%) 327 122
Topic revision: r6 - 23 Aug 2008 - 11:08:12 - Bruce Parrello
 
Notice to NMPDR Users - The NMPDR BRC contract has ended and bacterial data from NMPDR has been transferred to PATRIC (http://www.patricbrc.org), a new consolidated BRC for all NIAID category A-C priority pathogenic bacteria. NMPDR was a collaboration among researchers from the Computation Institute of the University of Chicago, the Fellowship for Interpretation of Genomes (FIG), Argonne National Laboratory, and the National Center for Supercomputing Applications (NCSA) at the University of Illinois. NMPDR is funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract HHSN266200400042C. Banner images are copyright © Dennis Kunkel.